tetraethylammonium has been researched along with Cardiomyopathies in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casis, O | 1 |
| Gallego, M | 1 |
| Iriarte, M | 1 |
| Sánchez-Chapula, JA | 1 |
1 other study available for tetraethylammonium and Cardiomyopathies
| Article | Year |
|---|---|
Effects of diabetic cardiomyopathy on regional electrophysiologic characteristics of rat ventricle.
Topics: 4-Aminopyridine; Action Potentials; Animals; Cardiomyopathies; Cells, Cultured; Diabetes Mellitus, E | 2000 |